The agency said it will work to develop multiple monoclonal antibodies, which help block a virus from infecting human cells.
Regeneron previously worked on a similar treatment for Ebola and MERS.
Read the full news release here.
More articles on pharmacy:
Walgreens pays $7.5M to resolve claims an employee impersonated a pharmacist
SwedishAmerican opens ScriptCenter, a self-serve pharmacy kiosk
Walgreens CEO talks strategy, skips buyout speculation at annual meeting
Next Up in Pharmacy
-
The FDA has accepted a biologics license application from Inovio for a potential treatment for adults with recurrent respiratory papillomatosis.…
-
As regulatory pressure mounts and workforce shortages persist, Louisville, Ky.-based Baptist Health System is positioning pharmacy as a safeguard for…
-
The following hospitals and health systems have recently posted job listings for pharmacy leaders. Note: This is not an exhaustive…
Join the 500,000+ healthcare executives who start their day with Becker’s
